Showing 681 - 700 results of 134,209 for search '(( 2 c decrease ) OR ( 5 ((we decrease) OR (((nn decrease) OR (a decrease)))) ))', query time: 2.08s Refine Results
  1. 681

    CDDO-Me radioprotection decreases with progressive oncogenic manipulations in HBECs and in a matched NSCLC line. by Mariam El-Ashmawy (678638)

    Published 2014
    “…Immortalized HBECs with (A) lenti-<i>KRas</i><sup>V12</sup>, (B) lenti-<i>KRas</i><sup>V12</sup> and sh<i>p53</i> knockdown, and (C) lenti-<i>KRas</i><sup>V12</sup>, sh<i>p53</i>, and <i>myc</i> overexpression. …”
  2. 682
  3. 683
  4. 684
  5. 685
  6. 686

    Loss of Cntnap2 decreases specifically stabilization of new spines. by Amos Gdalyahu (3213810)

    Published 2015
    “…<p><b>a.</b> From left to right: Chronic imaging through a cranial window of L5 pyramidal neuron. …”
  7. 687

    Cumulative effects and geographic distribution of mCHG-decreasing alleles. by Eriko Sasaki (501178)

    Published 2022
    “…Chr1:4035022 (<i>JMJ26</i>) was excluded from the analysis of CMT2-targeted transposons as it has no effect. Chr5:2355910 was used for <i>MSI1</i>. …”
  8. 688

    Vasopressin decreases EPSPs in CA2 after LTP induction. by Magda Chafai (295116)

    Published 2013
    “…Values are expressed as % of the mean of the responses recorded during 5 min before AVP application. C) Average graph (n = 6) showing that the IPSP component of the CA2 response to EC LIII stimulation was not affected by AVP. …”
  9. 689
  10. 690
  11. 691
  12. 692
  13. 693
  14. 694

    Rac and PKB activities are required for a late phase of cerebellar LTP. by Claire Jackson (362873)

    Published 2010
    “…<p><b>A</b>) Addition of the Rac inhibitor EHT1864 (50 µM; n = 7) to pipette solution decreases LTP duration. …”
  15. 695

    Vectorized siRNA TMPRSS2-ERG IV-SQ impaired tumour growth and restored differentiation <i>in vivo</i>. by Giorgia Urbinati (554921)

    Published 2015
    “…<p><b>a.</b> SCID mice (n = 5/group) bearing VCaP tumour xenografts were injected intravenously either with NaCl 0.9%, non-vectorized siRNA TMPRSS2-ERG IV, NPs siRNA control-SQ or NPs siRNA TMPRSS2-ERG IV-SQ twice per week during 6 weeks (1.8 mg/kg/mouse cumulative dose). …”
  16. 696
  17. 697
  18. 698

    Forbush Decrease Catalog at MESSENGER by Emma Davies (12046748)

    Published 2022
    “…Finally, the number of steps observed (1, 2, or C for complex), the quality rating (1--4, from highest to lowest) and the ratio between the 1st and 2nd slope (if present) are given.…”
  19. 699

    DataSheet_1_Decreased Survival of Invasive Ductal Breast Cancer Patients With Two Macrometastatic Lymph Nodes Among Few Resected Ones: Should Current Sentinel-Lymph-Node Guidelines... by Felipe A. C. Luz (11153445)

    Published 2021
    “…The positive-to-analyzed LN proportion demonstrated a strong prognostic factor for a low rate (1 positive to ≤1.5 analyzed) [HR = 1.567 (1.156–2.126), p = 0.004], and analysis derived from the results demonstrated that a “negative LN margin” improves survival. …”
  20. 700

    DataSheet_1_Decreased Survival of Invasive Ductal Breast Cancer Patients With Two Macrometastatic Lymph Nodes Among Few Resected Ones: Should Current Sentinel-Lymph-Node Guidelines... by Felipe A. C. Luz (11153445)

    Published 2021
    “…The positive-to-analyzed LN proportion demonstrated a strong prognostic factor for a low rate (1 positive to ≤1.5 analyzed) [HR = 1.567 (1.156–2.126), p = 0.004], and analysis derived from the results demonstrated that a “negative LN margin” improves survival. …”